Approval · Notice of Compliance 33085 · 2024
DALACIN C: Notice of Compliance 33085
Issued April 18, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33085
- Date
- April 18, 2024
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety update to the product monograph initiated by the sponsor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DALACIN C | Not yet assigned | — |
Medicinal ingredients
- CLINDAMYCIN HCL 150 MG per CAP
- CLINDAMYCIN HCL 300 MG per CAP